• Covers 88 genes
• Detects RNA-specific splicing variants
• Detects known and novel fusions
• Confirms and extends DNA-based variant detection
Identifies known and novel fusion genes
Detection of novel splicing events that cannot be seen at the DNA level
Efficient capture of cfRNA from as little as 2 mL of plasma
Liquid biopsy including low-input samples
Whole blood
Plasma
2-5 mL plasma
4-10 mL whole blood
14 days
PredicineRNA™ is a laboratory developed test. It is for research use only.
Our pilot program is available to select biopharma and academic partners to accelerate biomarker discoveries and biomarker-driven clinical studies. To initiate a study, contact us via the form below.
If you have any questions or need assistance, complete this form and we will respond within 24 hours.